Literature DB >> 11295694

Detection of inflammation in aortic aneurysms with indium 111-oxine--labeled leukocyte imaging.

K Takahashi1, M Ohyanagi, K Ikeoka, M Masai, H Naruse, T Iwasaki, M Fukuchi, T Miyamoto.   

Abstract

BACKGROUND: The exact cause of aortic aneurysms is not completely understood. Histologically, the atherosclerotic lesions present in an aneurysm contain numerous inflammatory cells. This finding represents active atherosclerosis, which can cause lesion expansion. In this study we investigated the role of scintigraphy in the evaluation of inflammation in aortic aneurysms. METHODS AND
RESULTS: We performed imaging using indium 111-oxine--labeled leukocytes in 14 patients with aortic aneurysms (10 thoracic and 4 abdominal) diagnosed by computed tomography. Peripheral blood evidence of inflammation was assessed on the same day. In 8 patients who subsequently underwent graft replacement of the aneurysm, the excised specimen was examined for evidence of inflammatory infiltration and correlated with the scintigraphic findings. Scintigraphic accumulation of labeled leukocytes was present in 10 of the 14 patients. Although all patients had a small increase in the erythrocyte sedimentation rate, there was no significant difference in the erythrocyte sedimentation rate between patients with positive and negative scintigram results. In 5 of the 8 surgical patients with positive scintigram results, the resected specimens demonstrated numerous inflammatory cells in the adventitia of the aortic wall and atherosclerotic changes in the media. There was no correlation between the presence of periaortic inflammatory adhesions at the time of surgery and the scintigraphic results.
CONCLUSIONS: The accumulation of In-111-oxine--labeled leukocytes is a potentially useful scintigraphic marker of inflammatory infiltration in aortic aneurysms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295694     DOI: 10.1067/mnc.2001.110209

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  23 in total

1.  Complement activation and subclassification of tissue immunoglobulin G in the abdominal aortic aneurysm.

Authors:  J F Capella; D C Paik; N X Yin; J E Gervasoni; M D Tilson
Journal:  J Surg Res       Date:  1996-09       Impact factor: 2.192

Review 2.  Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem.

Authors:  R W Thompson
Journal:  Curr Opin Cardiol       Date:  1996-09       Impact factor: 2.161

3.  Retroperitoneal approach for repair of inflammatory aortic aneurysms.

Authors:  G J Todd; J J DeRose
Journal:  Ann Vasc Surg       Date:  1995-11       Impact factor: 1.466

4.  Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke.

Authors:  A Cohen; C Tzourio; B Bertrand; C Chauvel; M G Bousser; P Amarenco
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

5.  Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis.

Authors:  W Casscells; B Hathorn; M David; T Krabach; W K Vaughn; H A McAllister; G Bearman; J T Willerson
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

6.  Unrestricted usage of immunoglobulin heavy chain genes in B cells infiltrating the wall of atherosclerotic abdominal aortic aneurysms.

Authors:  L J Walton; J T Powell; D V Parums
Journal:  Atherosclerosis       Date:  1997-11       Impact factor: 5.162

7.  Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response.

Authors:  A E Koch; G K Haines; R J Rizzo; J A Radosevich; R M Pope; P G Robinson; W H Pearce
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

8.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms.

Authors:  A E Koch; S L Kunkel; W H Pearce; M R Shah; D Parikh; H L Evanoff; G K Haines; M D Burdick; R M Strieter
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study.

Authors:  D H Montgomery; J J Ververis; G McGorisk; S Frohwein; R P Martin; W R Taylor
Journal:  J Am Coll Cardiol       Date:  1996-01       Impact factor: 24.094

10.  Anti-CD 18 monoclonal antibody slows experimental aortic aneurysm expansion.

Authors:  M A Ricci; G Strindberg; J M Slaiby; R Guibord; L J Bergersen; P Nichols; E D Hendley; D B Pilcher
Journal:  J Vasc Surg       Date:  1996-02       Impact factor: 4.268

View more
  3 in total

Review 1.  PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality?

Authors:  Gary R Small; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

2.  Group B streptococcal (GBS) bacteremia with mycotic thoracic aortic aneurysm and suppurative pericardial effusion.

Authors:  Brent Matsuda; Aaron Hoo; Ornusa Teerasukjinda; Heath Chung; Jinichi Tokeshi
Journal:  Hawaii J Med Public Health       Date:  2014-09

3.  Comparative study of abdominal and thoracic aortic aneurysms: their pathogenesis and a gingival fibroblasts-based ex vivo treatment.

Authors:  Hafida Cherifi; Bruno Gogly; Ludwig-Stanislas Loison-Robert; Ludovic Couty; François Côme Ferré; Ali Nassif; Antoine Lafont; Benjamin Pj Fournier
Journal:  Springerplus       Date:  2015-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.